These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

70 related articles for article (PubMed ID: 1499166)

  • 1. In vitro production of interleukin-1 from blood mononuclear cells of patients on chronic hemodialysis therapy.
    Haubitz M; Klöppel B; Lonnemann G; Nonnast-Daniel B
    Clin Nephrol; 1992 Jul; 38(1):30-5. PubMed ID: 1499166
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increased production of interleukin-10 and inflammatory cytokines in blood monocytes of hemodialysis patients.
    Morita Y; Yamamura M; Kashihara N; Makino H
    Res Commun Mol Pathol Pharmacol; 1997 Oct; 98(1):19-33. PubMed ID: 9434312
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A radioimmunoassay for human interleukin-1 alpha: measurement of IL-1 alpha produced in vitro by human blood mononuclear cells stimulated with endotoxin.
    Lonnemann G; Endres S; van der Meer JW; Cannon JG; Dinarello CA
    Lymphokine Res; 1988; 7(2):75-84. PubMed ID: 3261380
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effects of hemodialysis (HD) membranes on interleukin 1-beta (IL-1 beta) production from peripheral blood mononuclear cells (PBMC).
    Momoi T; Ono M; Takagi T; Sugiura S; Ogawa H; Saito A
    Clin Nephrol; 1995 Nov; 44 Suppl 1():S24-8. PubMed ID: 8608657
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fc gamma receptor cross-linking down-regulates IL-1 receptor antagonist and induces IL-1 beta in mononuclear phagocytes stimulated with endotoxin or Staphylococcus aureus.
    Marsh CB; Pope HA; Wewers MD
    J Immunol; 1994 May; 152(9):4604-11. PubMed ID: 8157973
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interleukin-1 and interleukin-2 production by peripheral blood mononuclear cells of patients with rheumatoid arthritis.
    Rozenbaum M; Scharf Y; Katz R; Pollack S
    Isr J Med Sci; 1989 Jul; 25(7):372-6. PubMed ID: 2788150
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Balance between IL-1 beta, TNF-alpha, and their specific inhibitors in chronic renal failure and maintenance dialysis. Relationships with activation markers of T cells, B cells, and monocytes.
    Descamps-Latscha B; Herbelin A; Nguyen AT; Roux-Lombard P; Zingraff J; Moynot A; Verger C; Dahmane D; de Groote D; Jungers P
    J Immunol; 1995 Jan; 154(2):882-92. PubMed ID: 7814891
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Peripheral blood mononuclear cells from patients with chronic renal failure release factors which suppress erythropoietin secretion in vitro.
    Cassidy MJ; De Jager C; Ebrahim O; Camachio P; Robson S
    Nephrol Dial Transplant; 1994; 9(7):775-9. PubMed ID: 7970119
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cytokine production by mononuclear cells from patients with chronic renal failure.
    Weinstein T; Fishman P; Djaldetti M; Levi J
    Isr J Med Sci; 1993 Apr; 29(4):183-6. PubMed ID: 8491567
    [TBL] [Abstract][Full Text] [Related]  

  • 10. T cells in patients undergoing chronic hemodialysis: mitogenic response, suppressor activity, and interleukin-2 production and receptor generation.
    Raskova J; Ghobrial I; Shea SM; Ebert EC; Eisinger RP; Raska K
    Diagn Immunol; 1986; 4(4):209-16. PubMed ID: 2944684
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Spontaneous production of, and defective response to, interleukin-1 by peripheral blood mononuclear cells from patients with scleroderma.
    Alcocer-Varela J; Martinez-Cordero E; Alarcon-Segovia D
    Clin Exp Immunol; 1985 Mar; 59(3):666-72. PubMed ID: 3872755
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synergetic effect of dialyzer membrane and lipopolysaccharide on peripheral blood mononuclear cell cytokine production in uremic patients.
    Gu Y; Ding F; Qin H; Zhao H; Lin S
    Chin Med J (Engl); 2000 Apr; 113(4):315-9. PubMed ID: 11775226
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vivo and in vitro effects of simvastatin on inflammatory markers in pre-dialysis patients.
    Panichi V; Paoletti S; Mantuano E; Manca-Rizza G; Filippi C; Santi S; Taccola D; Donadio C; Tramonti G; Innocenti M; Casto G; Consani C; Sbragia G; Franzoni F; Galetta F; Panicucci E; Barsotti G
    Nephrol Dial Transplant; 2006 Feb; 21(2):337-44. PubMed ID: 16249194
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Plasma interleukin-1 activity in humans undergoing hemodialysis with regenerated cellulosic membranes.
    Lonnemann G; Bingel M; Koch KM; Shaldon S; Dinarello CA
    Lymphokine Res; 1987; 6(2):63-70. PubMed ID: 3495707
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dialysis membranes decrease immunoglobulin and interleukin-6 production by peripheral blood mononuclear cells in vitro.
    Paczek L; Schaefer RM; Heidland A
    Nephrol Dial Transplant; 1991; 6 Suppl 3():41-4. PubMed ID: 1775266
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The influence of uremic serum on interleukin-1beta and interleukin-1 receptor antagonist production by peripheral blood mononuclear cells.
    Higuchi T; Fukuda N; Yamamoto C; Yamazaki T; Oikawa O; Ohnishi Y; Okada K; Soma M; Matsumoto K
    Ther Apher Dial; 2006 Feb; 10(1):65-71. PubMed ID: 16556139
    [TBL] [Abstract][Full Text] [Related]  

  • 17. B-cell activation and immunoregulation in end-stage renal disease patients receiving hemodialysis.
    Raskova J; Ghobrial I; Czerwinski DK; Shea SM; Eisinger RP; Raska K
    Arch Intern Med; 1987 Jan; 147(1):89-93. PubMed ID: 3492183
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthesis of interleukin-1 beta in primary biliary cirrhosis: relationship to treatment with methotrexate or colchicine and disease progression.
    Miller LC; Sharma A; McKusick AF; Tassoni JP; Dinarello CA; Kaplan MM
    Hepatology; 1995 Aug; 22(2):518-24. PubMed ID: 7635420
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Normal human alveolar macrophages obtained by bronchoalveolar lavage have a limited capacity to release interleukin-1.
    Wewers MD; Rennard SI; Hance AJ; Bitterman PB; Crystal RG
    J Clin Invest; 1984 Dec; 74(6):2208-18. PubMed ID: 6334697
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Low response to HBsAg vaccine in chronic renal failure patients is not due to intrinsic defect of B cells.
    Krishnamurthy G; Kher V; Naik S
    Scand J Urol Nephrol; 2002; 36(5):377-82. PubMed ID: 12487744
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.